Correlation Between Vicore Pharma and I Tech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vicore Pharma and I Tech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vicore Pharma and I Tech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vicore Pharma Holding and I Tech, you can compare the effects of market volatilities on Vicore Pharma and I Tech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vicore Pharma with a short position of I Tech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vicore Pharma and I Tech.

Diversification Opportunities for Vicore Pharma and I Tech

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Vicore and ITECH is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Vicore Pharma Holding and I Tech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on I Tech and Vicore Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vicore Pharma Holding are associated (or correlated) with I Tech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of I Tech has no effect on the direction of Vicore Pharma i.e., Vicore Pharma and I Tech go up and down completely randomly.

Pair Corralation between Vicore Pharma and I Tech

Assuming the 90 days trading horizon Vicore Pharma is expected to generate 5.75 times less return on investment than I Tech. In addition to that, Vicore Pharma is 1.36 times more volatile than I Tech. It trades about 0.03 of its total potential returns per unit of risk. I Tech is currently generating about 0.24 per unit of volatility. If you would invest  8,275  in I Tech on April 30, 2025 and sell it today you would earn a total of  3,175  from holding I Tech or generate 38.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vicore Pharma Holding  vs.  I Tech

 Performance 
       Timeline  
Vicore Pharma Holding 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vicore Pharma Holding are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Vicore Pharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
I Tech 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in I Tech are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, I Tech unveiled solid returns over the last few months and may actually be approaching a breakup point.

Vicore Pharma and I Tech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vicore Pharma and I Tech

The main advantage of trading using opposite Vicore Pharma and I Tech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vicore Pharma position performs unexpectedly, I Tech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in I Tech will offset losses from the drop in I Tech's long position.
The idea behind Vicore Pharma Holding and I Tech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities